BALSM MEDICAL

Balsm Alofoq Medical Company

9620StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operating Summary
Revenue	19.86M	18.03M	17.01M
Cost of Revenue	10.47M	9.87M	8.70M
Gross Profit	9.38M	8.17M	8.31M
SG&A	4.69M	4.15M	4.68M
Operating Expenses	4.27M	3.82M	4.58M
Operating Income	5.12M	4.34M	3.73M
Interest Expense	-71.71K	-85.12K	-99.24K
Pretax Income	5.04M	4.26M	3.63M
Income Tax	264.20K	96.75K	120.54K
Net Income	4.78M	4.16M	3.51M
EBITDA	6.05M	5.17M	4.63M
EBIT	5.12M	4.34M	3.73M
EPS (Basic)	2.34	2.82	—
EPS (Diluted)	2.34	2.82	—
DPS	1.50	—	—
Margins & Efficiency
Gross Margin %	+47.3%	+45.3%	+48.9%
EBITDA Margin %	+30.5%	+28.6%	+27.2%
Net Margin %	+24.1%	+23.1%	+20.7%
Revenue & Income
Revenue	19.86M	18.03M	17.01M
Revenue Growth (YoY)	+10.1%	+6.0%	—
Expenses & Provisions
Advertising Expenses	429.43K	363.15K	165.05K
Cost of Revenue	10.47M	9.87M	8.70M
Selling, General & Admin	4.69M	4.15M	4.68M
Operating Expenses	4.27M	3.82M	4.58M
Other Operating Expenses	—	—	-106.27K
Interest Expense	-71.71K	-85.12K	-99.24K
D&A For EBITDA	930.86K	822.26K	900.50K
Profitability & Returns
Gross Profit	9.38M	8.17M	8.31M
Gross Margin	+47.3%	+45.3%	+48.9%
EBIT	5.12M	4.34M	3.73M
EBIT Margin	+25.8%	+24.1%	+22.0%
EBITDA	6.05M	5.17M	4.63M
EBITDA Margin	+30.5%	+28.6%	+27.2%
Pretax Income	5.04M	4.26M	3.63M
Operating Income	5.12M	4.34M	3.73M
Operating Margin	+25.8%	+24.1%	+22.0%
Profit Margin	+24.1%	+23.1%	+20.7%
Net Income	4.78M	4.16M	3.51M
Net Income to Common	4.78M	4.16M	3.51M
Net Income Growth	+14.8%	+18.5%	—
Income Tax Expense	264.20K	96.75K	120.54K
Effective Tax Rate	+5.2%	+2.3%	+3.3%
Per Share & Capital
EPS (Basic)	2.34	2.82	—
EPS (Diluted)	2.34	2.82	—
EPS Growth	-17.0%	—	—
Dividend Per Share	1.50	—	—
Shares Change (YoY)	0.38	—	—
Shares Outstanding (Basic)	2.04M	1.48M	—
Shares Outstanding (Diluted)	2.04M	1.48M	—
Free Cash Flow	5.27M	-1.74M	4.53M
Free Cash Flow Margin	+26.5%	-9.7%	+26.6%
Free Cash Flow Per Share	2.58	-1.18	—
Payout Ratio	+62.8%	+23.1%	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operating Summary
Revenue	19.86M	18.03M	17.01M
Cost of Revenue	10.47M	9.87M	8.70M
Gross Profit	9.38M	8.17M	8.31M
SG&A	4.69M	4.15M	4.68M
Operating Expenses	4.27M	3.82M	4.58M
Operating Income	5.12M	4.34M	3.73M
Interest Expense	-71.71K	-85.12K	-99.24K
Pretax Income	5.04M	4.26M	3.63M
Income Tax	264.20K	96.75K	120.54K
Net Income	4.78M	4.16M	3.51M
EBITDA	6.05M	5.17M	4.63M
EBIT	5.12M	4.34M	3.73M
EPS (Basic)	2.34	2.82	—
EPS (Diluted)	2.34	2.82	—
DPS	1.50	—	—
Margins & Efficiency
Gross Margin %	+47.3%	+45.3%	+48.9%
EBITDA Margin %	+30.5%	+28.6%	+27.2%
Net Margin %	+24.1%	+23.1%	+20.7%
Revenue & Income
Revenue	19.86M	18.03M	17.01M
Revenue Growth (YoY)	+10.1%	+6.0%	—
Expenses & Provisions
Advertising Expenses	429.43K	363.15K	165.05K
Cost of Revenue	10.47M	9.87M	8.70M
Selling, General & Admin	4.69M	4.15M	4.68M
Operating Expenses	4.27M	3.82M	4.58M
Other Operating Expenses	—	—	-106.27K
Interest Expense	-71.71K	-85.12K	-99.24K
D&A For EBITDA	930.86K	822.26K	900.50K
Profitability & Returns
Gross Profit	9.38M	8.17M	8.31M
Gross Margin	+47.3%	+45.3%	+48.9%
EBIT	5.12M	4.34M	3.73M
EBIT Margin	+25.8%	+24.1%	+22.0%
EBITDA	6.05M	5.17M	4.63M
EBITDA Margin	+30.5%	+28.6%	+27.2%
Pretax Income	5.04M	4.26M	3.63M
Operating Income	5.12M	4.34M	3.73M
Operating Margin	+25.8%	+24.1%	+22.0%
Profit Margin	+24.1%	+23.1%	+20.7%
Net Income	4.78M	4.16M	3.51M
Net Income to Common	4.78M	4.16M	3.51M
Net Income Growth	+14.8%	+18.5%	—
Income Tax Expense	264.20K	96.75K	120.54K
Effective Tax Rate	+5.2%	+2.3%	+3.3%
Per Share & Capital
EPS (Basic)	2.34	2.82	—
EPS (Diluted)	2.34	2.82	—
EPS Growth	-17.0%	—	—
Dividend Per Share	1.50	—	—
Shares Change (YoY)	0.38	—	—
Shares Outstanding (Basic)	2.04M	1.48M	—
Shares Outstanding (Diluted)	2.04M	1.48M	—
Free Cash Flow	5.27M	-1.74M	4.53M
Free Cash Flow Margin	+26.5%	-9.7%	+26.6%
Free Cash Flow Per Share	2.58	-1.18	—
Payout Ratio	+62.8%	+23.1%	—